Skip to main content
SpringerLink
Log in

Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy

  • ORIGINAL ARTICLE
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

N-Terminal-probrain natriuretic peptide (NT-proBNP) plasma levels are elevated in patients with congestive heart failure. Published data concerning the utility of NT-proBNP in hypertrophic cardiomyopathy (HCM) are lacking. Our aim was to evaluate the clinical significance of NT-proBNP in patients with HCM. A blood sample was collected for plasma NT-proBNP measurement from 43 consecutive patients with documented HCM. NT-proBNP was measured using a chemiluminescent immunoassay kit (Roche Diagnostics) on an Elecsys 2010 analyzer. Median value of NT-proBNP was 219 pg/ml (range 8–3 045 pg/ml) in NYHA class I patients, 698 pg/ml (125–2 463 pg/ml) in NYHA class II patients, and 2 683 pg/ml (131–11 542 pg/ml) in NYHA class III and IV patients. NT-proBNP plasma levels were significantly higher across the severity of functional limitation (i.e., NYHA class classification) (P = 0.002). NT-proBNP levels were significantly higher in female than male (P = 0.034), in referral vs nonreferral patients (P = 0.004), in symptomatic vs asymptomatic patients (P = 0.020), in patients with basal subaortic gradient ≥30 mmHg (P = 0.001) and in the patients who were on cardioactive medication (P = 0.010). In univariate analysis NT-proBNP was significantly correlated with age (P < 0.001), left ventricular maximum wall thickness (P = 0.001), left atrial size (P = 0.019), and subaortic gradient ≥30 mmHg (P < 0.001). In multivariate regression analysis, age (P < 0.001), maximum wall thickness (P = 0.007), and gradient ≥30 mmHg (P = 0.027) were independently associated with NT-proBNP levels. Our data support the idea that measurement of plasma NT-proBNP levels in HCM patients is useful to assess their clinical status, especially the severity of hypertrophy and the presence of obstruction, although age must be taken into account.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. BJ Maron (1997) ArticleTitleHypertrophic cardiomyopathy Lancet 350 127–133 Occurrence Handle9228976 Occurrence Handle10.1016/S0140-6736(97)01282-8 Occurrence Handle1:STN:280:DyaK2sznt12hsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  2. BJ Maron JM Gardin JM Flack SS Gidding TT Kurosaki DE Bild (1995) ArticleTitlePrevalence of hypertrophic cardiomyopathy in a general population of young adults Circulation 92 785–789 Occurrence Handle7641357 Occurrence Handle1:STN:280:DyaK2MzmvVyisg%3D%3D

    PubMed  CAS  Google Scholar 

  3. A Abchee AJ Marian (1997) ArticleTitlePrognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy J Invest Med 45 191–196 Occurrence Handle1:STN:280:DyaK2s3pvVyqtQ%3D%3D

    CAS  Google Scholar 

  4. JC Moolman VA Corfield B Posen K Ngumbela C Seidman PA Brink H Watkins (1997) ArticleTitleSudden death due to troponin T mutations J Am Coll Cardiol 29 549–555 Occurrence Handle9060892 Occurrence Handle10.1016/S0735-1097(96)00530-X Occurrence Handle1:STN:280:DyaK2s3hsVGisA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  5. BJ Maron I Olivotto P Spirito SA Casey P Bellone TE Gohman KJ Graham DA Burton F Cecchi (2000) ArticleTitleEpidemiology of hypertrophic cardiomyopathy-related death: revisited in a large nonreferral-based patient population Circulation 102 858–864 Occurrence Handle10952953 Occurrence Handle1:STN:280:DC%2BD3cvhvFWhuw%3D%3D

    PubMed  CAS  Google Scholar 

  6. SS Lele HL Thomson H Seo I Belenkie WJ McKenna MP Frenneaux (1995) ArticleTitleExercise capacity in hypertrophic cardiomyopathy: role of stroke volume limitation, heart rate, and diastolic filling characteristics Circulation 92 2886–2894 Occurrence Handle7586256 Occurrence Handle1:STN:280:DyaK28%2FntFeitw%3D%3D

    PubMed  CAS  Google Scholar 

  7. MP Frenneaux A Porter AL Caforio H Odawara PJ Counihan WJ McKenna (1992) ArticleTitleDeterminants of exercise capacity in hypertrophic cardiomyopathy J Am Coll Cardiol 19 1521–1526

    Google Scholar 

  8. P Nihoyannopoulos G Karatasakis M Frenneaux WJ McKenna CM Oakley (1992) ArticleTitleDiastolic function in hypertrophic cardiomyopathy: relation to exercise capacity J Am Coll Cardiol 19 536–540 Occurrence Handle1538006 Occurrence Handle1:STN:280:DyaK387ms1WktQ%3D%3D

    PubMed  CAS  Google Scholar 

  9. C Briguori S Betocchi M Romano F Manganelli M Angela Losi Q Ciampi R Gottilla R Lombardi M Condorelli M Chiariello (1999) ArticleTitleExercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function Am J Cardiol 84 309–315 Occurrence Handle10496441 Occurrence Handle10.1016/S0002-9149(99)00282-9 Occurrence Handle1:STN:280:DyaK1MvisVOlsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  10. BJ Maron P Spirito KJ Green YE Wesley RO Bonow J Arce (1987) ArticleTitleNoninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 10 733–742 Occurrence Handle3655141 Occurrence Handle1:STN:280:DyaL1c%2FgvVKqsA%3D%3D

    PubMed  CAS  Google Scholar 

  11. PA McCullough KR Sandberg (2003) ArticleTitleSorting out the evidence on natriuretic peptides Rev Cardiovasc Med 4 IssueIDSuppl 4 S13–S19 Occurrence Handle14564224

    PubMed  Google Scholar 

  12. AM Richards R Doughty MG Nicholls S MacMahon N Sharpe J Murphy EA Espiner C Frampton TG Yandle (2001) ArticleTitlePlasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group J Am Coll Cardiol 37 1781–1787 Occurrence Handle11401111 Occurrence Handle10.1016/S0735-1097(01)01269-4 Occurrence Handle1:CAS:528:DC%2BD3MXltVGhsLw%3D

    Article  PubMed  CAS  Google Scholar 

  13. V Kirk M Bay J Parner K Krogsgaard TM Herzog S Boesgaard C Hassager OW Nielsen J Aldershvile H Nielsen (2004) ArticleTitleN-terminal proBNP and mortality in hospitalized patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF) Eur J Heart Fail 6 335–341 Occurrence Handle14987585 Occurrence Handle10.1016/j.ejheart.2004.01.002 Occurrence Handle1:CAS:528:DC%2BD2cXhsFWqsLY%3D

    Article  PubMed  CAS  Google Scholar 

  14. P Bettencourt A Azevedo J Pimenta F Frioes S Ferreira A Ferreira (2004) ArticleTitleN-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2168–2174 Occurrence Handle15451800 Occurrence Handle10.1161/01.CIR.0000144310.04433.BE Occurrence Handle1:CAS:528:DC%2BD2cXotFGksLk%3D

    Article  PubMed  CAS  Google Scholar 

  15. C Fisher C Berry L Blue JJ Morton J McMurray (2003) ArticleTitleN-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure Heart 89 879–881 Occurrence Handle12860863 Occurrence Handle10.1136/heart.89.8.879 Occurrence Handle1:STN:280:DC%2BD3szjtVOqtA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  16. RS Gardner F Ozalp AJ Murday SD Robb TA McDonagh (2003) ArticleTitleN-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure Eur Heart J 24 1735–1743 Occurrence Handle14522568 Occurrence Handle10.1016/j.ehj.2003.07.005 Occurrence Handle1:CAS:528:DC%2BD3sXns1Krt74%3D

    Article  PubMed  CAS  Google Scholar 

  17. HG Klues A Schiffers BJ Maron (1995) ArticleTitlePhenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients J Am Coll Cardiol 26 1699–1708 Occurrence Handle7594106 Occurrence Handle10.1016/0735-1097(95)00390-8 Occurrence Handle1:STN:280:DyaK28%2FotlGntw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  18. BJ Maron (2002) ArticleTitleHypertrophic cardiomyopathy: A systematic review JAMA 287 1308–1320 Occurrence Handle11886323 Occurrence Handle10.1001/jama.287.10.1308

    Article  PubMed  Google Scholar 

  19. MS Maron I Olivotto S Betocchi SA Casey JR Lesser MA Losi F Cecchi BJ Maron (2003) ArticleTitleEffect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 295–303 Occurrence Handle12540642 Occurrence Handle10.1056/NEJMoa021332

    Article  PubMed  Google Scholar 

  20. S Sharma P Elliott G Whyte S Jones N Mahon B Whipp WJ McKenna (2000) ArticleTitleUtility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy Am J Cardiol 86 162–168 Occurrence Handle10913477 Occurrence Handle10.1016/S0002-9149(00)00854-7 Occurrence Handle1:STN:280:DC%2BD3czpvFGrtg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  21. BJ Maron P Spirito (1998) ArticleTitleImplications of left ventricular remodeling in hypertrophic cardiomyopathy Am J Cardiol 81 1339–1344 Occurrence Handle9631972 Occurrence Handle10.1016/S0002-9149(98)00164-7 Occurrence Handle1:STN:280:DyaK1c3ptlOgsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  22. DJ Sahn A DeMaria J Kisslo A Weyman (1978) ArticleTitleRecommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1072–1083 Occurrence Handle709763 Occurrence Handle1:STN:280:DyaE1M%2Fktl2msw%3D%3D

    PubMed  CAS  Google Scholar 

  23. JA Panza RK Petrone L Fananapazir BJ Maron (1992) ArticleTitleUtility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 19 91–99 Occurrence Handle1729351 Occurrence Handle1:STN:280:DyaK387gsFKitA%3D%3D Occurrence Handle10.1016/0735-1097(92)90057-T

    Article  PubMed  CAS  Google Scholar 

  24. GK Efthimiadis G Giannakoulas DG Parharidou HI Karvounis ST Mochlas IH Styliadis S Gavrielides KD Gemitzis GD Giannoglou GE Parharidis GE Louridas (2006) ArticleTitlePrevalence of systolic impairment in an unselected regional population with hypertrophic cardiomyopathy Am J Cardiol 98 1269–1272 Occurrence Handle17056344 Occurrence Handle10.1016/j.amjcard.2006.05.063

    Article  PubMed  Google Scholar 

  25. InstitutionalAuthorNameRoche Diagnostics (2002) ProBrain natriuretic peptide package insert Roche Diagnostics Indianapolis

    Google Scholar 

  26. InstitutionalAuthorNameBiosite (2002) TriageBNP package insert Biosite San Diego

    Google Scholar 

  27. K Ogino K Ogura T Kinugawa S Osaki M Kato Y Furuse Y Kinugasa Y Tomikura O Igawa I Hisatome C Shigemasa (2004) ArticleTitleNeurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy Circ J 68 444–450 Occurrence Handle15118286 Occurrence Handle10.1253/circj.68.444

    Article  PubMed  Google Scholar 

  28. BJ Maron VN Tholakanahalli AG Zenovich SA Casey D Duprez DM Aeppli JN Cohn (2004) ArticleTitleUsefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy Circulation 109 984–989 Occurrence Handle14967727 Occurrence Handle10.1161/01.CIR.0000117098.75727.D8 Occurrence Handle1:CAS:528:DC%2BD2cXhsFeisbk%3D

    Article  PubMed  CAS  Google Scholar 

  29. T Nakamura K Sakamoto T Yamano M Kikkawa K Zen T Hikosaka T Kubota A Azuma T Nishimura (2002) ArticleTitleIncreased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with nonobstructive hypertrophic cardiomyopathy J Am Coll Cardiol 39 1657–1663 Occurrence Handle12020494 Occurrence Handle10.1016/S0735-1097(02)01813-2 Occurrence Handle1:CAS:528:DC%2BD38XktlGquro%3D

    Article  PubMed  CAS  Google Scholar 

  30. Y Mizuno M Yoshimura E Harada M Nakayama T Sakamoto Y Shimasaki H Ogawa K Kugiyama Y Saito K Nakao H Yasue (2000) ArticleTitlePlasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy Am J Cardiol 86 1036–1040 Occurrence Handle11053725 Occurrence Handle10.1016/S0002-9149(00)01147-4 Occurrence Handle1:CAS:528:DC%2BD3cXnsFWqsb8%3D

    Article  PubMed  CAS  Google Scholar 

  31. C Briguori S Betocchi F Manganelli B Gigante MA Losi Q Ciampi R Gottilla A Violante CG Tocchetti M Volpe M Chiariello (2001) ArticleTitleDeterminants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy Eur Heart J 22 1328–1336 Occurrence Handle11465965 Occurrence Handle10.1053/euhj.2000.2535 Occurrence Handle1:STN:280:DC%2BD3Mvhs12ksw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  32. K Hasegawa H Fujiwara K Doyama M Miyamae T Fujiwara S Suga M Mukoyama K Nakao H Imura S Sasayama (1993) ArticleTitleVentricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy Circulation 88 372–380 Occurrence Handle8339400 Occurrence Handle1:STN:280:DyaK3szjvVymtQ%3D%3D

    PubMed  CAS  Google Scholar 

  33. PJ Hunt AM Richards MG Nicholls TG Yandle RN Doughty EA Espiner (1997) ArticleTitleImmunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment Clin Endocrinol (Oxf) 47 287–296 Occurrence Handle10.1046/j.1365-2265.1997.2361058.x Occurrence Handle1:CAS:528:DyaK2sXms1Shu7w%3D

    Article  CAS  Google Scholar 

  34. S Masson T Vago G Baldi M Salio N De Angelis E Nicolis AP Maggioni R Latini G Norbiato M Bevilacqua (2002) ArticleTitleComparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure Clin Chem Lab Med 40 761–763 Occurrence Handle12392300 Occurrence Handle10.1515/CCLM.2002.130 Occurrence Handle1:CAS:528:DC%2BD38XosFygurc%3D

    Article  PubMed  CAS  Google Scholar 

  35. TJ Wang MG Larson D Levy EP Leip EJ Benjamin PW Wilson P Sutherland T Omland RS Vasan (2002) ArticleTitleImpact of age and sex on plasma natriuretic peptide levels in healthy adults Am J Cardiol 90 254–258 Occurrence Handle12127613 Occurrence Handle10.1016/S0002-9149(02)02464-5 Occurrence Handle1:CAS:528:DC%2BD38XlsVKrurg%3D

    Article  PubMed  CAS  Google Scholar 

  36. J Li L Wang (2006) ArticleTitleB-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation Heart Vessels 21 137–140 Occurrence Handle16715186 Occurrence Handle10.1007/s00380-005-0884-y

    Article  PubMed  Google Scholar 

  37. E Arteaga AQ Araujo P Buck BM Ianni R Rabello C Mady (2005) ArticleTitlePlasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy Am Heart J 150 1228–1232 Occurrence Handle16338263 Occurrence Handle10.1016/j.ahj.2005.02.045 Occurrence Handle1:CAS:528:DC%2BD2MXhtlais7rL

    Article  PubMed  CAS  Google Scholar 

  38. R Thaman MT Esteban S Barnes JR Gimeno B Mist R Murphy PO Collinson WJ McKenna PM Elliott (2006) ArticleTitleUsefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy Am J Cardiol 98 515–519 Occurrence Handle16893708 Occurrence Handle10.1016/j.amjcard.2006.02.057 Occurrence Handle1:CAS:528:DC%2BD28XotFKisbg%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Cardiology Department, AHEPA Hospital, Aristotle University, Thessaloniki, Greece

    Georgios K. Efthimiadis, Georgios Giannakoulas, Anastasia Mitakidou, Theodoros Karamitsos, Haralambos Karvounis, Sotirios Mochlas, Ioannis Stylıadis, Haris Stefanidis, Georgios Parcharidis & Georgios Louridas

  2. Laboratory of Lipids and Prevention of Cardiovascular Disease, AHEPA Hospital, Aristotle University, Thessaloniki, Greece

    Areti Hitoglou-Makedou

Authors
  1. Georgios K. Efthimiadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Areti Hitoglou-Makedou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Georgios Giannakoulas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anastasia Mitakidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Theodoros Karamitsos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Haralambos Karvounis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sotirios Mochlas
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ioannis Stylıadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Haris Stefanidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Georgios Parcharidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Georgios Louridas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georgios K. Efthimiadis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Efthimiadis, G., Hitoglou-Makedou, A., Giannakoulas, G. et al. Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy. Heart Vessels 22, 322–327 (2007). https://doi.org/10.1007/s00380-007-0976-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-007-0976-y

Key words

Search

Navigation